Literature DB >> 34263154

Results of Excision of Unknown Papillary Neoplasms Detected on Core Biopsy.

Ayşe Nur Uğur Kılınç1, Zeynep Bayramoğlu1, Yaşar Ünlü1, Nahide Baran2, Ayşegül Altunkeser2, Nergis Aksoy3, Mehmet Ali Eryılmaz3, Elif Nur Öztürk Yıldırım4.   

Abstract

OBJECTIVE: This study aimed to find out valuable parameters that predict the nature of breast papillary lesions before excision, and we compared our results with those in the literature.
MATERIALS AND METHODS: We reviewed the medical records and pathology slides of patients diagnosed with papillary neoplasm after undergoing a core-needle biopsy between 2010 and 2020, who, subsequently, underwent surgical excision in a single tertiary care institution. The core biopsy results and pathology results of excision materials were compared with the radiological, pathological, and demographic findings.
RESULTS: A total of 51 patients were included in the study. According to the excision results, the patients were divided into two groups: the atypical group, which included 20 patients (39.3%), and the benign group, which included 31 patients (61.7%). The results of the core biopsy showed that the loss of myoepithelial cell layer was identified in 18 patients in the atypical group, while it was present in all patients in the benign group. Tumor sizes were larger and patient ages were older in the atypical group compared with the benign group. No significant difference was found between atypical and benign groups in terms of breast imaging-reporting and data system (BI-RADS) classification and location (right vs left; central vs peripheral). The upgrade rate was between 0% and 16% in literature, while it was 4% in our study.
CONCLUSION: There is no consensus on whether patients diagnosed with papillary neoplasia as a result of core biopsy will undergo excision. According to our results, patients with following criteria should have their lesions excised: those who are advanced in age, those who are diagnosed with a papillary lesion as a result of core biopsies with loss of myoepithelial cell layer, and those who are diagnosed with large-sized lesions without loss of myoepithelial cell layer. Patients diagnosed with small-sized lesions without loss of myoepithelial cell layer and who are young in age are to be followed up without the need for lesion excision. The lesions should be adequately sampled. ©Copyright 2021 by Turkish Federation of Breast Diseases Associations.

Entities:  

Keywords:  Breast neoplasm; core biopsy; papillary neoplasm

Year:  2021        PMID: 34263154      PMCID: PMC8246050          DOI: 10.4274/ejbh.galenos.2021.6101

Source DB:  PubMed          Journal:  Eur J Breast Health


  12 in total

1.  Benign papilloma without atypia diagnosed at US-guided 14-gauge core-needle biopsy: clinical and US features predictive of upgrade to malignancy.

Authors:  Ji Hyun Youk; Eun-Kyung Kim; Jin Young Kwak; Eun Ju Son; Byeong-Woo Park; Seung-Il Kim
Journal:  Radiology       Date:  2010-10-22       Impact factor: 11.105

2.  Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision.

Authors:  Anupma Nayak; Selin Carkaci; Michael Z Gilcrease; Ping Liu; Lavinia P Middleton; Roland L Bassett; Jinxia Zhang; Hong Zhang; Robin L Coyne; Therese B Bevers; Nour Sneige; Lei Huo
Journal:  Clin Breast Cancer       Date:  2013-10-08       Impact factor: 3.225

3.  Concordant, non-atypical breast papillomas do not require surgical excision: A 10-year multi-institution study and review of the literature.

Authors:  Lars J Grimm; Christine E Bookhout; Rex C Bentley; Sheryl G Jordan; Thomas J Lawton
Journal:  Clin Imaging       Date:  2018-05-01       Impact factor: 1.605

4.  Diagnostic evaluation of papillary lesions of the breast on core biopsy.

Authors:  Nirmala Pathmanathan; Ann-Flore Albertini; Pamela J Provan; Jane S Milliken; Elizabeth L Salisbury; A Michael Bilous; Karen Byth; Rosemary L Balleine
Journal:  Mod Pathol       Date:  2010-05-14       Impact factor: 7.842

5.  Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors.

Authors:  Xin Wen; Wen Cheng
Journal:  Ann Surg Oncol       Date:  2012-08-10       Impact factor: 5.344

6.  Management of papillary breast lesions diagnosed on core-needle biopsy: clinical pathologic and radiologic analysis of 276 cases with surgical follow-up.

Authors:  Monica Rizzo; Jared Linebarger; Michael C Lowe; Lin Pan; Sheryl G A Gabram; Leonel Vasquez; Michael A Cohen; Marina Mosunjac
Journal:  J Am Coll Surg       Date:  2012-01-11       Impact factor: 6.113

7.  Upgrading rate of papillary breast lesions diagnosed by core-needle biopsy.

Authors:  Cholatip Wiratkapun; Tanaporn Keeratitragoon; Panuwat Lertsithichai; Niramol Chanplakorn
Journal:  Diagn Interv Radiol       Date:  2013 Sep-Oct       Impact factor: 2.630

8.  The significance of combined CK5/6 and p63 immunohistochemistry in predicting the risks of subsequent carcinoma development in intraductal papilloma of the breast.

Authors:  Yang Yang; Koyu Suzuki; Eriko Abe; Chihping Li; Mieko Uno; Futoshi Akiyama; Hideko Yamauchi; Mari Kikuchi; Sachiko Ohde; Gautam Deshpande; Yukiko Shibahara; Yasuhiro Nakamura; Hironobu Sasano
Journal:  Pathol Int       Date:  2015-01-08       Impact factor: 2.534

9.  Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy?

Authors:  S Nicholas Agoff; Thomas J Lawton
Journal:  Am J Clin Pathol       Date:  2004-09       Impact factor: 2.493

10.  Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.

Authors:  Fresia Pareja; Adriana D Corben; Sandra B Brennan; Melissa P Murray; Zenica L Bowser; Kiran Jakate; Christopher Sebastiano; Monica Morrow; Elizabeth A Morris; Edi Brogi
Journal:  Cancer       Date:  2016-06-17       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.